CN
|
EN
Home
Introduction to the 2023 CBIIC
Main Conference
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Agenda
Previous Speakers
News
Expert
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Business Matching Service
Register
Roadshow Application
Onsite Participant Registration
CN
EN
M&A Commercialization Forum
Agendas
13:30 - 17:30
并购商业化论坛
M & A Commercialization Forum
Moderator
赵佳 , 阿斯利康战略合作与业务发展部总监
Emma ZHAO , Director, Alliances & Business Development, Astrazeneca
13:30 - 15:30
第一阶段:主题报告
Session I: Keynote Speeches
13:30 - 14:00
主题报告1
Keynote Speech 1
新周期下医疗健康投资和并购机遇
Healthcare Investment and M&A Opportunities in the New Age
孙佳林 高特佳投资集团总经理
SUN Jialin , General Manager, Shenzhen GTJA Investment Group Co., Ltd.
14:00 - 14:30
主题报告2
Keynote Speech 2
Biotech商业拓展路径分享:持续推动核心技术创新,布局多元化全球合作
Business Development for Biotech: Diversified Global Partnership Model Based on Continuous Evolution of Leading Technologies
戎一平 和铂医药首席科学官
RONG Yiping , CSO, Harbour BioMed
14:30 - 15:00
主题报告3
Keynote Speech 3
研发管线商业化:药企技术许可+股权投资热点问题解析
R&D Pipeline Commercialization: Hot Topics on Technology License & Equity Finance Involving Biopharmas
陶旭东 君合律师事务所医药医疗业务部主管合伙人
TAO Xudong , Senior Partner and Head of Life Science Stream, JunHe LLP
15:00 - 15:30
主题报告4
Keynote Speech 4
红筹结构概述及合规化处理
Overview of Red Chip Structure and Compliance Processing
王贯达 睿智天下咨询(北京)有限公司创始人&CEO
WANG Guanda , CEO, Witsus Consulting(Beijing)Co.,Ltd.
15:30 - 17:30
第二阶段:专题讨论
Session II: Panel
15:30 - 16:30
讨论1
Panel 1
从投资到产业的智慧变革
Smart Transformation from Investment to Industry
Moderator
姜华, 山东博安生物技术股份有限公司董事长兼CEO
Sammy JIANG, Chairlady & CEO, Boan Biotech
Panelists
朱忠远,映恩生物创始人兼CEO
John ZHU,Founder and CEO of Duality Biologics
杨颖莹,泉创资本执行董事
Yingying YANG,Principal, Quan Capital
赵瑞麟,应脉医疗科技(上海)有限公司首席执行官
ZHAO Ruilin,CEO, Enlight Medical Technologies (Shanghai) Co., Ltd.
李萧,睿智天下咨询(北京)有限公司华东区管理负责人
Hope LI,Regional Managing Director, Eastern China,Witsus Consulting(Beijing)Co.,Ltd.
16:30 - 17:30
讨论2
Panel 2
探寻创新药企并购与“出海”新模式
Exploration of New Model of M&A and “Going Global” for Innovative Pharmaceutical Enterprises
Moderator
刘宁 , 君合律师事务所合伙人
LIU Ning , Partner, JunHe LLP
Panelists
肖振宇,通德资本董事长兼CEO
XIAO Zhenyu,Chairman & CEO of Hermed Capital
曹飞,应世生物联合创始人兼首席运营官
CAO Fei,Co-founder &COO of InxMed
黄智,百济神州大中华区首席财务官&全球技术运营及生产部门财务负责人
Eric HUANG,Greater China CFO & Finance Head of Global TechOps, BeiGene
曹尚,君实生物法务与知识产权部负责人、业务发展部负责人
Alex CAO,Head of Legal and IP, Head of Business Development, Junshi Biosciences
王贯达,睿智天下咨询(北京)有限公司创始人&CEO
WANG Guanda,CEO, Witsus Consulting(Beijing)Co.,Ltd.